What are chemical signs of life beyond Earth?
To look for molecules that point to life, scientists seek to understand what makes biochemistry different from everything else
Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Copyright © 2023 American Chemical Society
November 30, 2020 Cover
Volume 98, Issue 46
To look for molecules that point to life, scientists seek to understand what makes biochemistry different from everything else
Cover image:Chemists ponder which molecular signatures matter
Credit: Chad Hagen
Volume 98 |
Issue 46
Quote of the Week
Astrochemistry
5 new technologies that are making an impact
C&EN takes a look at innovation emerging from the chemical industry’s big players
Europe’s drug supply chain gets ready for a makeover
As the European Commission prepares a new pharmaceutical strategy, manufacturers seek financial support and technology investment
-
Periodic Graphics: Toxins in fruits and vegetables
Chemical educator and Compound Interest blogger Andy Brunning points out some of the toxic compounds in the fruits and veggies we eat
-
Cheaper cryo-EM on the horizon
Thermo Fisher hopes $1 million microscope could broaden access to microscopy method used to determine protein structures
-
Pfizer, Moderna ready vaccine manufacturing networks
A mesh of contract services will be activated by both the big pharma and the smaller biotech
ADVERTISEMENT
Adenoviral vector vaccine data both promising and perplexing
Preliminary results from AstraZeneca and Oxford’s Phase 3 trial of their COVID-19 vaccine suggest a smaller dose is better than a full dose
